Adamis Pharmaceuticals Corporation ADMP

$ 0.78 0.86%

Quarterly report 2023-Q3
added 11-14-2023

Adamis Pharmaceuticals Corporation Deferred Revenue 2011-2024 | ADMP

Annual Deferred Revenue Adamis Pharmaceuticals Corporation

2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
27.8 K	100 K	100 K	916 K	1.01 M	14.8 K	54.5 K	-	-	-	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
1.01 M	14.8 K	318 K

Quarterly Deferred Revenue Adamis Pharmaceuticals Corporation

2023-Q3	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
173 K	27.8 K	27.8 K	27.8 K	100 K	100 K	100 K	100 K	104 K	121 K	100 K	100 K	100 K	100 K	116 K	116 K	116 K	916 K	1.01 M	1.01 M	1.01 M	1.01 M	14.8 K	14.8 K	10.9 K	14.8 K	54.5 K	54.5 K	54.5 K	54.5 K	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
1.01 M	10.9 K	229 K